Peijia Medical Limited Stock

Equities

9996

KYG6981F1090

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. 04:08:03 2024-03-28 am EDT 5-day change 1st Jan Change
3.66 HKD -3.94% Intraday chart for Peijia Medical Limited -.--% -50.47%

Financials

Sales 2023 441M 60.88M 477M Sales 2024 * 682M 94.07M 736M Capitalization 2.28B 315M 2.47B
Net income 2023 -393M -54.24M -425M Net income 2024 * -246M -33.95M -266M EV / Sales 2023 10.3 x
Net cash position 2023 * 887M 122M 958M Net cash position 2024 * 480M 66.26M 519M EV / Sales 2024 * 2.64 x
P/E ratio 2023
-11.6 x
P/E ratio 2024 *
-9.39 x
Employees 1,040
Yield 2023 *
-
Yield 2024 *
-
Free-Float 64.64%
More Fundamentals * Assessed data
Dynamic Chart
JenaValve Technology, Inc. announced that it has received $100.4 million in funding from a group of investors CI
Peijia Medical Limited Delays in Publication of 2023 Annual Results CI
Peijia Medical Narrows 2023 Loss as Revenue Jumps 76% MT
Peijia Medical Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Peijia Medical Announces Successful Completion of Patient Enrollment for Pivotal TaurusTrio Transcatheter Aortic Regurgitation Clinical Trial CI
Peijia Medical's 2023 Profit to Jump Up to 79.4% MT
Peijia Medical Limited Announces Unaudited Revenue Results for the Year Ended December 31, 2023 CI
Peijia Medical's Stock Jumps on Positive Updates For Two Devices MT
Peijia Medical Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Peijia Medical Enrolls First Patient in TaurusTrio Transcatheter System; Shares Up 4% MT
Peijia Medical Limited Announces First Patient in Multi-Center Registration Clinical Trial of Taurustrio?? Transcatheter Aortic Valve Replacement System in China CI
Peijia Medical's H1 Revenue Rises By Up to 94% MT
Peijia Medical Limited Provides Unaudited Revenue Guidance for the Period from January 1, 2023 to June 30, 2023 CI
China Approves Peijia Medical Unit's Micro Guidewire for Neuro-Intervention Operations MT
Peijia Medical Limited Receives Approval from the National Medical Products Administration of the PRC for the Registration Application of DCwireTM Micro Guidewire CI
More news
1 day-3.94%
1 month-8.04%
3 months-26.06%
6 months-41.53%
Current year-50.47%
More quotes
1 month
3.54
Extreme 3.54
3.94
Current year
3.54
Extreme 3.54
7.76
1 year
3.54
Extreme 3.54
9.92
3 years
3.54
Extreme 3.54
39.10
5 years
3.54
Extreme 3.54
39.10
10 years
3.54
Extreme 3.54
39.10
More quotes
Managers TitleAgeSince
Founder 51 12-05-29
Chief Executive Officer 54 12-05-29
Director of Finance/CFO 43 19-03-31
Members of the board TitleAgeSince
Director/Board Member 73 20-01-20
Director/Board Member 79 20-01-20
Director/Board Member 59 20-01-20
More insiders
Peijia Medical Ltd is a China-based holding company mainly engaged in the research and development of interventional procedural medical devices. Through its subsidiaries, the Company operates two segments. Transcatheter Valve Therapeutic Business segment is mainly engaged in the development of transcatheter valve therapeutic medical devices. Neurointerventional Business segment is engaged in the research and development of neurointerventional procedural medical devices. The Company's main products under development include TaurusOne, TaurusElite, TaurusNXT and others. The Company operates its businesses primarily in domestic market.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
3.38 CNY
Average target price
11.1 CNY
Spread / Average Target
+228.38%
Consensus

Annual profits - Rate of surprise